The aNKs expressed more death ligands on their cell surface compared to circulating peripheral blood NK cells (Figure S3C-E), while PI treatment led to increases in the surface expression of Fas and DR4 on AML cells (Fig. 2B). The gene discussed is TNFRSF10A; the disease is acute myeloid leukemia.